Immobilisation or disuse is a condition known to be associated with a decrease in bone mass, osteopenia and in some people leading to osteoporosis with an increased risk of fractures. In this condition, previous histomorphometric and biochemical reports have shown an uncoupling between bone formation and resorption, but the exact sequence of the events resulting in bone loss is still not fully understood. In spinal cord injury for instance, the main finding soon after the onset is decreased osteoblastic activity associated with a dramatic increase in bone degradation. The overall consequence of these metabolic events is the development of a rapid and severe osteoporosis only observed in the paralysed part of the body associated with the loss of biomechanical strength and the biosynthesis of a structurally modified matrix which is unable to sustain normal mechanical stress. This situation dramatically increases the risk of fractures. The same uncoupling phenomenon has been described in healthy individuals who have been submitted to long duration bedrest and also in astronauts during spaceflight; but the timing, intensity and the metabolic subset may be different as these people do recover after cessation of the disuse period, which does not occur in paralysed patients. As new accurate and sensitive non-invasive techniques have become available recently to assess bone and connective tissue metabolism, more information is now available regarding bone loss in paralysed and/or immobilised individuals. These techniques should be definitely helpful in orientating new therapeutic trials with drugs and/or procedures intended to correct the musculoskeletal deleterious effects of disuse. This paper is therefore aimed at a review of bone metabolism in those with a severe spinal cord injury, or with a long duration of bedrest, or with loss of biomechanical function, or with actual or simulated spaceflight, in all instances using non-invasive techniques.
Introduction
Generic terms such as 'disuse' or 'immobilisation osteoporosis' have been used currently to describe the skeletal changes that occur in situations such as long-term bed rest, spaceflight or simulated weight lessness, loss of normal biomechanical function, and in neurological disorders associated with acute or chronic paralysis. The terminology used certainly does not reflect the aetiopathogenic factors involved in the occurrence of bone loss in any of these situations which are most likely to appear multifactorial in most of the examples. Nevertheless the loss of the normal bio mechanical stress associated with some degree of 
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Bone metabolism in spinal cord injury patients
In spinal cord injury patients (SCI), some alterations in bone metabolism can be reproducibly observed in cluding a rapid and intense bone loss occurring pre dominantly in the paralysed limbs, hypercalcemia and hypercalciuria, and increased hydroxyproline excre tion. An invasive technique such as bone histomorpho metry has demonstrated a 33% decrease of the trabecu lar bone volume measured on iliac crest biopsies associated with increased bone resorption surfaces, a reduced bone formation rate1 and an increased bone marrow fat content.2 Using non-invasive techniques, such as dual-photon absorptiometry (DPA) it is pos sible to quantify bone loss more accurately. Using DPA, many studies have confirmed the rapid and important decrease of bone mass. Biering-Sorensen et al have observed in a 3 years prospective study a 50% decrease in bone mineral content in the paralysed limbs of SCI patients, mostly at the femoral neck and the proximal metaphysis of the tibia.3 Bone loss in the paralysed segments of the body has also been studied by transversal studies. [4] [5] [6] [7] More recently it has been demonstrated that total-body bone mass was also significantly decreased by -12% in paraplegic subjects6 and indeed all skeletal sites appeared to be concerned, with the exception of the skull.8 Recent data originat ing from our group confirm that bone mass is directly affected by paralysis, but muscle mass and fat mass are also affected. Using dual X-ray absorptiometry to assess whole-body composition in a prospective study including six young male SCI patients presenting with an acute complete traumatic paraplegia: bone mineral content (BMC) and density (BMD) of the lumbar spine and of the skull did not vary between the 1st (T1) and the 6th (T6) month after onset. In sharp contrast, in the lower limbs (LL) BMC decreased by 7.1% and BMD by 6.4% during the same time whilst there was a 4.8% increase in the upper limbs (UL) BMC. Whole-body BMC and BMD did not vary significantly between T1 and T6. LL-Lean body mass (LBM) decreased by 10.7% whereas it increased significantly by 19.6% in the UL during the same time. The total LBM decreased by 5% between T1 and T3, but no further loss could be measured up to T6. LL-Fat body mass (FBM) in creased by 39% but no change was seen in the UL during the time. The total FBM increased by 23% between T1 and T6 (D Uebelhart et aI, personal results). Bone mass homeostasis is difficult to assess precisely, but most authors agree that major bone loss occurs during the first 6 months after spinal cord in j ury, and stabilizes between 12-16 months at -2/3 of original bone mass, near the fracture threshold. Based upon available data, the overall bone loss occurring during the first months after onset was certainly overestimated by previous studies, mainly because of the large imprecision of the DPA technique used.
Paralysis is accompanied by a broad spectrum of metabolic disturbances which can be evaluated by various biological measurements. In addition to the well known hypercalcemic and hypercalciuric response which is due to the massive mobilisation of calcium from the mineral phase of bone tissue,9-12 the organic phase of bone is equally affected by paralysis, as is suggested by the increased initial urinary excretion of hydroxyproline which returns to baseline pre-injury levels between 6-12 months after the onset of the paralysisY-14 Recently, more sensitive and/or specific biochemical markers of bone metabolism have been measured in SCI patients. For instance osteocalcin (OC), a marker of bone formation, was found to be increased in 13 SCI patients in a recent cross-sectional study of Pietschmann et aI, 14 whereas in six patients followed longitudinally, normal OC levels were found at one month after injury but OC values continuously increased thereafter during the 6 months of follow-up. Zan one et at found the same trend in a longitudinal study including 41 SCI patients; OC levels were in the lower range of the normal values by the end of the first month after onset and then increased to peak at month 7 after onset. 15 Bergmann et at found a similar increase in serum OC in 11 paraplegic patients followed up for 3 months. 7 The initial depression in the osteoblastic response measured by OC was recently confirmed by our group as well as a decrease in the biosynthesis of type I collagen assessed by the measurement of type I procollagen levels in serum. 16 It is interesting that in growing rats, Wakley et al showed that periosteum isolated from tibiae and femurs had decreased mRNA levels for osteocalcin, alkaline phosphatase and even tually the prepro-alpha I subunit of type I collagen between 1 and 2 weeks after they were submitted to unilateral sciatic neurectomyY In SCI patients, Pietschmann et at found increased urinary hydroxy proline/creatinine levels which peaked at month 4 after injury, and increased urinary calcium/creatinine which peaked at month 2. Serum levels of intact parathor mone, which represents the biologically active form of the hormone, were low initially and became normal 6 months after the onset.14 Bergmann et at measured tartrate-resistant acid phosphatase (TRAP) levels in the serum, a marker of osteoclastic activity. TRAP levels were in the upper range of the controls during the first month after onset and decreased thereafter. 7 Recently we demonstrated a dramatic and continuous increase in sensitive bone resorption markers such as urinary pyridinoline and deoxy-pyridinoline and serum carboxy-terminal telopeptide of type I collagen begin ning as early as 2 weeks after onset of SCI. 16 Additional data from our group suggest that a peak in bone resorption occurs between 2-3 months after onset (D. Uebelhart et aI, personal results). In addition we showed that serum type III procollagen were dramatic ally increased after SCI, suggesting an increased turnover of connective tissues. 16
Bone metabolism in simulated weightlessness
In simulated weightlessness, the effects of immobilisa tion occur without neurological injury and osteopenia and appear to be primarily due to a reduced rate of bone formation. This was clearly shown in the well described rat model of simulated weightlessness with hind-limbs elevation and unloading while maintaining normal weight bearing on the forelimbs.18 Vitamin D metabolism has been shown to be modified by simu lated weightlessness in growing animals with a signifi cant decrease in circulating 1,25-(OH)2D after skeletal unloading, but it appeared to be secondary to the hypercalcemic response observed in the animals. 19 In addition, there is recent evidence that skeletal unload ing induces a resistance to IGF-l action.20 Recently, Genty et al used the tail suspension model of Morey Holton in adult rats and showed a 40% decrease of osteoid surfaces after 7 days of suspension in the unloaded left proximal tibia which was associated in vitro with a 70% decrease of alkaline phosphatase activity of isolated osteoblasts.21 If these immobilisa tion studies clearly indicate that in animals, unloading of a skeletal structure invariably leads to bone loss and decreased bone formation in the affected part, Grynpas et al showed that a postcranial 2 week immobilisation of the jaw bone in young Rhesus monkeys significantly changed the density profile of mandibular bone, an element that retained function during the immobilisa tion period. In fact, a decrease in the quantity of bone in the lower density fractions could be observed at the end of the immobilisation period, which was associated with a decreased bone OC content, both findings being consistent with a decreased bone formation in the jaw. Because the effect occurred rapidly in a non-immobil ised and non-weight-bearing bone and persisted for at least one week after remobilisation, the authors sug gested a systemic effect of the immobilisation on the skeleton. 22
Bone metabolism during spaceflight Actual spaceflight has also been reported to have tremendous effects on bone metabolism, but most results are difficult to interpret because of great methodological variation. However, generalised bone loss does not appear to be a consequence of micro gravity but mainly occurs in localised skeletal areas according to the level of modelling and remodelling and of the support function of each bone in normal gravity.23 Decreased OC gene expression has been reported by Backup et al in the bone tissue of young rats after 4 days of space flight. 24 Schneider et al studied bone mineral density (BMD) before and after space flight of 131 to 312 days duration in nine cosmonauts of the MIR Space Station. Despite an active exercise program during the period in space, a 7.4 % loss in the pelvis BMD, 5% and 9% respectively in the femoral neck and trochanter, and a 4.2% increase in the head BMD were found. Whole-body BMD did not change during the follow-up period, whereas a decreased lean mass and an increased fat content in the lower limbs was found. 25
Bone metabolism after loss of normal biomechanical function
Loss of biomechanical function invariably results in subsequent bone loss. For instance, in scoliotic patients immobilised by a plaster jacket, Bronner et al showed a significant reduction in bone formation which was quantitatively greater than the increased resorption which occurred after immobilisation.26 Immobilisation Bone metabolism in immobile individuals D Uebelhart el al of the forelimb of dogs in a spica cast for up to 60 weeks resulted in significant spongy and compact bone loss at the level of the third metacarpal. Histomorphometric analysis showed that it was more pronounced in younger animals which presented with 70% trabecular and 60% cortical bone loss after 2 months of immobil isation, compared with respectively, 55% and 50% in older animals. Interestingly, the animals remobilised after 32 weeks of casting showed a very significant increase in their bone content clearly suggesting a positive effect of remobilisation on recovery of bone loss during the active phase of dis�se.27 By immobilis ing a rat hind limb by knee tenotomy, Thompson et al were able to show a significant increase of osteoclasts as early as 30 h after tenotomy, an increase in bone resorption surfaces after 72 h and a decrease in trabecu lar bone volume after 240 h in the tenotomised tibiae. Bone resorption could be prevented by indomethacin, but it did not prevent the decrease of bone formation during the 10 days of the experiment.28 Adult male monkeys restrained in a semirecumbent position according to Howard et al 29 for 7 months demonstrated progressive osteopenic changes in their tibial compact bone. Histologically, osteoblastic activity was sup pressed and resorption cavities were increased only in some portions of the total tibial section.3o Mechanic et al confirmed these results on adult male pigtail monkeys restrained for 7 months with cancellation and osteopenia in tibial cortical bone, a loss of trabecular bone at the endosteal margin, alterations in the recruitment and activation of osteoclasts and a signifi cant increase in non-mineralized collagen content in total bone.31
Bone metabolism in long duration bedrest Using long duration bedrest studies, Schneider et al showed that healthy adults immobilised in bed present with a negative calcium balance after 2 weeks and after one month of immobilisation 200 mg of Ca are lost per day.32 LeBlanc et at showed that spinal bone mineral content decreased slightly (0.9% ) but not significantly after 5 weeks of bedrest. 33 Another study performed on six subjects lying horizontally in bed showed significant loss of BMD at various sites after 17 weeks of immobilisation: total body (-1.4% ), lumbar spine (-3.9% ), femoral neck (-3.6%), trochanter (-4.6% ), tibia (-2.2% ) and calcaneus (-10.4% ). After 6 months of reambulation, the calcaneus was the only bone presenting with a total BMD recovery. Interest ingly, a redistribution of bone mineral was observed during the bedrest period with an increase in skull BMD. The total-body BMD was highly correlated with the change in total-body calcium determined by cal cium balance. 34 Grigoriev et al measured mineral balances, hormone levels and BMD in nine subjects immobilised in bed with 5 degrees head-tilt down for 360 consecutive days and treated with an exercise program used for cosmonauts with or without EHDP: 900 mg daily. The negative calcium balance was re duced by 50% for the first 120 days, 80% for the second and 69% during the third 120 day period in the group treated with exercise and bisphosphonate. Exercise alone had no effect until the second 120 day period when the calcium balance improved 52% . BMD measured in the lumbar spine, femoral neck and diaphysis by DPA did not show any significant vari ation but femoral neck BMD appeared to decrease slightly in the group which received exercise alone. 35 Van der Wiel et al evaluated bone metabolism in 14 patients who had a lumbar disc protrusion and who were immobilised in bed for 10 days, and found an increased fasting hydroxyproline/creatinine ratio after 4 days of bed rest which peaked after 10 days. Interestingly, these levels did not return to baseline level 6 weeks after remobilisation. Fasting urinary calcium/creatinine ratio followed a similar pattern. Serum calcium and phosphorus increased significantly during immobilisation. Serum 1,25 Vit D3 decreased significantly due to the increased serum calcium and phosphate levels and reached a nadir one week after remobilisation. Total alkaline phosphatase did not vary during the immobilisation period. 36 Pedersen et al evaluated serum levels of carboxy terminal propeptide of type I collagen (PICP) and osteocalcin as well as urinary deoxy-pyridinoline (D-Pyr) in nine young women before and after 5 days of complete bed rest. Bed rest resulted in a 14% decrease in serum PICP accompanied by a fade in normal circadian rythm after 5 days of immobilisation. OC and D-Pyr increased during the same period.37
Structural changes in collagen as a molecular basis to explain bone loss in disuse Recently, some attention has been given to possible structural abnormalities in the collagen of bone in osteoporotic states. Normal adult bone matrix is mainly composed of type I collagen with only small amounts « 10% ) of minor collagens type III (5% ), V, and type VI which are nevertheless believed to play an impor tant role in the organisation of type I fibers. 38 Based on rat collagen turnover analysis, the half-life of type I collagen is 54.7 days and that of type III collagen 32.9 days. No difference was found between skin and bone collagen turnover. 39 Analysing bone sections from femoral head and neck regions of osteoporotic patients undergoing hip replacement surgery as compared with normal subjects, Bailey et al showed that total collagen content did not vary between the two populations. In sharp contrast, in osteoporotic bone samples, type III collagen content decreased, hydroxylation of lysine residues was dramatically increased, DHLNL content (a reducible cross-link of collagen) decreased dramatic ally, but no change could be detected in the pyridino line content (non-reducible cross-link of collagen). In SCI patients we recently found a dramatic increase in type III procollagen in the serum which could reflect the increased connective tissue metabolism. 16 In addi tion, the expression of collagen phenotype appeared to be modified since type VI collagen amount tended to decrease. 40 An altered level of lysyl hydroxylation of the alpha 2(1) chain of type I collagen in osteoporotic bone has also been demonstrated by Batge et al. 41 Notbohm et al have demonstrated that the thermo stability of type I collagen from osteoporotic patients was reduced and was inversely proportional to their degree of lysyl-overhydroxylation, which could in crease type I collagen susceptibility to proteolytic degradation.42
Conclusions
It appears that regional or whole-body bone loss is associated with situations such as bedrest, plaster casting, nerve or tendon section, paralysis and actual or simulated spaceflight. Most of the studies dealing with disuse or immobilisation have focused on the weight bearing skeleton; however there is now some evidence that the effects are not only due to a compromised biomechanical function, some of the changes do have a systematic base, such as in those with paralysis. A major difference between these different situations is the intensity and the timing of the bone metabolic responses which is definitively most important in those with paralysis, as compared with those with bedrest, and with simulated or actual spaceflight. As accurate and sensitive non-invasive techniques became available recently, new exciting information has been provided through whole-body or site specific bone mineral density measurements. In sharp contrast with the advancement made with bone densitometry, biochem ical modifications induced by disuse are only poorly understood, mainly because of the lack of sensitive and/or specific markers of bone metabolism. Using sensitive biochemical markers of bone metabolism in association with high precision and accurate densito metric techniques in prospective clinical studies should help to identify the factors responsible for the develop ment of secondary osteoporosis and help to define effective therapeutic strategies aimed at reducing the deleterious effects of disuse.
